Search Details

Word: researchers (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Other recent genetic research has backed up that notion. One study, published in PNAS in 2007 and led by John Hawks, an anthropologist at the University of Wisconsin at Madison, found that some 1,800 human gene variations had become widespread in recent generations because of their modern-day evolutionary benefits. Among those genetic changes, discovered by examining more than 3 million DNA variants in 269 individuals: mutations that allow people to digest milk or resist malaria and others that govern brain development. (Watch TIME's video "Darwin and Lincoln: Birthdays and Evolution...

Author: /time Magazine | Title: Darwin Lives! Modern Humans Are Still Evolving | 10/23/2009 | See Source »

After all of this research, the Lampoon wrote “Nightlight.” The writers used the “corpse” method, in which they sat at a table and went around saying one word at a time forming the story. After many, many hours of “corpsing” and some editing, the 160 page book was created...

Author: By EESHA D. DAVE, CONTRIBUTING WRITER | Title: Revamping Vampires | 10/22/2009 | See Source »

...Shifting Politics That makes the politics - and the lines of political influence - a lot more difficult to sort out. Whereas the traditional pharmaceutical industry is concentrated in just a couple of states, biotech firms have sprung up just about anywhere you find a university with a research hospital, which gives them a broad political base. "I know that vote hurt me at home," says Ohio Senator Sherrod Brown, who led the unsuccessful fight against the 12-year exclusivity in the Senate HELP Committee...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

...Indeed, the biologics lobby has become one of K Street's most powerful players. Working largely through BIO and the Pharmaceutical Research and Manufacturers of America (PhRMA), it has funded an extensive network that includes not only lobbyists but also think-tank experts and advocacy groups. "You can't get on the phone with someone who isn't getting paid," says an economist who has studied the biologics issue with funding from a drug company. "They give money to everyone and anyone...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

...operating support" from Pfizer and operates out of a small Washington law-firm office. It has been blitzing Capitol Hill with letters arguing that guaranteeing biologics makers fewer than 12 years of exclusivity in the use of their data could cost lives. The other group, the Alliance of Aging Research, is also run by the drug industry. Its chairman is the managing partner of Foxkiser, a drug-company consultant, and its vice chairman is with Novartis...

Author: /time Magazine | Title: How Drug-Industry Lobbyists Won on Health-Care | 10/22/2009 | See Source »

Previous | 251 | 252 | 253 | 254 | 255 | 256 | 257 | 258 | 259 | 260 | 261 | 262 | 263 | 264 | 265 | 266 | 267 | 268 | 269 | 270 | 271 | Next